Teachers Retirement System of The State of Kentucky Sells 24,418 Shares of Inspire Medical Systems, Inc. $INSP

Teachers Retirement System of The State of Kentucky lessened its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 78.6% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,651 shares of the company’s stock after selling 24,418 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Inspire Medical Systems were worth $343,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. CWM LLC grew its stake in Inspire Medical Systems by 216.1% during the fourth quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after buying an additional 242 shares in the last quarter. Havemeyer Place LP bought a new position in Inspire Medical Systems in the 4th quarter valued at about $39,000. V Square Quantitative Management LLC acquired a new position in shares of Inspire Medical Systems in the 4th quarter valued at approximately $40,000. Smartleaf Asset Management LLC lifted its holdings in shares of Inspire Medical Systems by 84.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock worth $42,000 after acquiring an additional 205 shares during the period. Finally, Larson Financial Group LLC lifted its holdings in shares of Inspire Medical Systems by 21,266.7% during the 3rd quarter. Larson Financial Group LLC now owns 641 shares of the company’s stock worth $48,000 after acquiring an additional 638 shares during the period. Institutional investors own 94.91% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on INSP shares. JPMorgan Chase & Co. reduced their price target on shares of Inspire Medical Systems from $67.00 to $54.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Mizuho cut their target price on Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating for the company in a research note on Tuesday, May 5th. Weiss Ratings downgraded Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 6th. Zacks Research upgraded Inspire Medical Systems from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Finally, Wells Fargo & Company decreased their price target on Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 5th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, fourteen have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $81.26.

Inspire Medical Systems Trading Up 1.5%

INSP opened at $51.24 on Friday. The company has a market cap of $1.48 billion, a P/E ratio of 11.41, a PEG ratio of 5.11 and a beta of 0.71. The company’s 50 day moving average is $44.23 and its 200-day moving average is $58.86. Inspire Medical Systems, Inc. has a 1-year low of $38.91 and a 1-year high of $147.03.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.38. The business had revenue of $204.58 million during the quarter, compared to analysts’ expectations of $200.04 million. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, equities analysts forecast that Inspire Medical Systems, Inc. will post 0.93 EPS for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.